Literature DB >> 29350301

Constipation in Parkinson's Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle?

Amol Sharma1, Julie Kurek2, John C Morgan2, Chandramohan Wakade3, Satish S C Rao4.   

Abstract

PURPOSE OF REVIEW: Chronic constipation is a common, nonmotor, and prodromal symptom in Parkinson's disease (PD). Its underlying neuropathology may provide pathophysiological insight into PD. Here, we critically review what is currently known about the neuroanatomical and brain-gut interactions, and the origin and progression of Lewy pathology (LP) at three levels-brain/brainstem, spinal cord, and enteric nervous system. RECENT
FINDINGS: Many recent studies have illustrated the challenges of examining LP in tissues obtained from colon biopsies of PD patients. Large-scale epidemiological studies have not confirmed the widely accepted Braakpostula. In this review, we propose an alternative origin and route of spread of LP in PD. We describe novel, noninvasive neurophysiological testing that could advance the understanding of LP and complex bidirectional brain-pelvic floor neural pathways in PD-a true disease model of a neurogastrointestinal disorder. This review may provide the impetus for future studies investigating gut and brain interaction and constipation in PD.

Entities:  

Keywords:  Constipation; Dyssynergic defecation; Enteric nervous system; Lewy bodies/neurites/pathology; Parkinson’s disease; α-Synuclein

Mesh:

Year:  2018        PMID: 29350301     DOI: 10.1007/s11894-018-0609-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  75 in total

Review 1.  Brain imaging and functional gastrointestinal disorders: has it helped our understanding?

Authors:  A R Hobson; Q Aziz
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 2.  Parkinson's disease: insights from pathways.

Authors:  Mark R Cookson; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

3.  Visceral afferent hypersensitivity in irritable bowel syndrome--evaluation by cerebral evoked potential after rectal stimulation.

Authors:  P Sinhamahapatra; S P Saha; A Chowdhury; S K Chakrabarti; A Ghosh; B Maiti
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

4.  Colonic transit time and rectoanal videomanometry in Parkinson's disease.

Authors:  R Sakakibara; T Odaka; T Uchiyama; M Asahina; K Yamaguchi; T Yamaguchi; T Yamanishi; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

5.  Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.

Authors:  Roberta Zangaglia; Emilia Martignoni; Margaret Glorioso; Maria Ossola; Giulio Riboldazzi; Daniela Calandrella; Gabriele Brunetti; Claudio Pacchetti
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

6.  Routine colonic biopsies as a new tool to study the enteric nervous system in living patients.

Authors:  T Lebouvier; E Coron; T Chaumette; S Paillusson; S Bruley des Varannes; M Neunlist; P Derkinderen
Journal:  Neurogastroenterol Motil       Date:  2009-07-21       Impact factor: 3.598

7.  Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Amélie Pelletier; Jacques Montplaisir
Journal:  Mov Disord       Date:  2013-03-28       Impact factor: 10.338

8.  Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A.

Authors:  Alberto Albanese; Giuseppe Brisinda; Anna Rita Bentivoglio; Giorgio Maria
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

9.  Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease.

Authors:  Andrea Gold; Zorbey T Turkalp; David G Munoz
Journal:  Mov Disord       Date:  2013-01-29       Impact factor: 10.338

10.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

View more
  8 in total

1.  Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson's Disease.

Authors:  Daniel Martinez-Ramirez; Edna Sophia Velazquez-Avila; Alejandro Almaraz-Espinoza; Arnulfo Gonzalez-Cantú; Genaro Vazquez-Elizondo; Daniel Overa-Posada; Amin Cervantes-Arriaga; Mayela Rodriguez-Violante; Mirna Gonzalez-Gonzalez
Journal:  Parkinsons Dis       Date:  2020-10-17

Review 2.  Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects.

Authors:  Chethan Ramprasad; Jane Yellowlees Douglas; Baharak Moshiree
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 3.  Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders.

Authors:  Amol Sharma; Satish S C Rao; Kimberly Kearns; Kimberly D Orleck; Scott A Waldman
Journal:  Aliment Pharmacol Ther       Date:  2021-04-28       Impact factor: 8.171

Review 4.  Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson's Disease.

Authors:  Tennekoon B Karunaratne; Chijioke Okereke; Marissa Seamon; Sharad Purohit; Chandramohan Wakade; Amol Sharma
Journal:  Nutrients       Date:  2020-12-23       Impact factor: 5.717

5.  Study on the characteristics of intestinal motility of constipation in patients with Parkinson's disease.

Authors:  Mei Zhang; Shuang Yang; Xiao-Cui Li; Hong-Ming Zhu; Ding Peng; Bang-Yi Li; Tian-Xu Jia; Chen Tian
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

6.  Physical activity and prodromal features of Parkinson disease.

Authors:  Katherine C Hughes; Xiang Gao; Samantha Molsberry; Linda Valeri; Michael A Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2019-11-12       Impact factor: 9.910

7.  Alpha sinuclein expression in blood and its relationship with chronic constipation in a population from Bogotá, D.C., with problems of alcohol consumption

Authors:  Tania Yadira Martínez-Rodríguez; Mauricio Rey-Buitrago
Journal:  Biomedica       Date:  2020-06-15       Impact factor: 0.935

Review 8.  Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.

Authors:  Steven D Mitchell; Christos Sidiropoulos
Journal:  Toxins (Basel)       Date:  2021-03-19       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.